YAP1 and neoplasm: Thus, additive effects that escalate Yki activity elicit qualitatively different effects, and this is likely to be relevant to both our own analysis of ab-driven tumours, as well as more generally to understanding how cooperating pathways synergise to drive tumourigenesis.